Satoko Hatano

4.1k total citations · 2 hit papers
14 papers, 3.2k citations indexed

About

Satoko Hatano is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Satoko Hatano has authored 14 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Satoko Hatano's work include Lung Cancer Research Studies (7 papers), Lung Cancer Treatments and Mutations (6 papers) and RNA modifications and cancer (5 papers). Satoko Hatano is often cited by papers focused on Lung Cancer Research Studies (7 papers), Lung Cancer Treatments and Mutations (6 papers) and RNA modifications and cancer (5 papers). Satoko Hatano collaborates with scholars based in Japan and India. Satoko Hatano's co-authors include Kengo Takeuchi, Hiroyuki Mano, Yuki Togashi, Manabu Soda, Young Lim Choi, Ken Nakagawa, Sakae Okumura, Yuichi Ishikawa, Yukitoshi Satoh and Kentaro Inamura and has published in prestigious journals such as Nature Medicine, PLoS ONE and Cancer.

In The Last Decade

Satoko Hatano

14 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

RET, ROS1 and ALK fusions in lung cancer

2012 963 citations Kengo Takeuchi, Manabu Soda et al. Nature Medicine profile →
KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer

2009 557 citations Kengo Takeuchi, Young Lim Choi et al. Clinical Cancer Research profile →

Peers

Satoko Hatano

PRM

ONCOL

MB

CR

PFM

Yuki Togashi Japan

Hannah Stubbs United States

Seiji Sakata Japan

Reimi Asaka Japan

Nabila Elarouci France

Bénédicte Buttard France

Lara Felicioni Italy

Luc Friboulet France

So Young Kang South Korea

James Suh United States

Yuki Togashi Japan

Satoko Hatano

3.1k ×1.2

PRM

2.3k ×1.2

ONCOL

1.6k ×1.3

MB

1.1k ×1.3

CR

619 ×1.3

PFM

Citations per year, relative to Satoko Hatano Satoko Hatano (= 1×) peers Yuki Togashi

Countries citing papers authored by Satoko Hatano

Since Specialization

Citations

This map shows the geographic impact of Satoko Hatano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoko Hatano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoko Hatano more than expected).

Fields of papers citing papers by Satoko Hatano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoko Hatano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoko Hatano. The network helps show where Satoko Hatano may publish in the future.

Co-authorship network of co-authors of Satoko Hatano

This figure shows the co-authorship network connecting the top 25 collaborators of Satoko Hatano. A scholar is included among the top collaborators of Satoko Hatano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoko Hatano. Satoko Hatano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Hamanaka, Wakako, Noriko Motoi, Shumpei Ishikawa, et al.. (2014). A subset of small cell lung cancer with low neuroendocrine expression and good prognosis: a comparison study of surgical and inoperable cases with biopsy. Human Pathology. 45(5). 1045–1056. 32 indexed citations

2.

Togashi, Yuki, Manabu Soda, Seiji Sakata, et al.. (2012). KLC1-ALK: A Novel Fusion in Lung Cancer Identified Using a Formalin-Fixed Paraffin-Embedded Tissue Only. PLoS ONE. 7(2). e31323–e31323. 205 indexed citations

3.

Sugawara, Emiko, Yuki Togashi, Naoto Kuroda, et al.. (2012). Identification of anaplastic lymphoma kinase fusions in renal cancer. Cancer. 118(18). 4427–4436. 103 indexed citations

4.

Takeuchi, Kengo, Manabu Soda, Yuki Togashi, et al.. (2012). RET, ROS1 and ALK fusions in lung cancer. Nature Medicine. 18(3). 378–381. 963 indexed citations breakdown →

5.

Takeuchi, Kengo, Manabu Soda, Yuki Togashi, et al.. (2011). Pulmonary Inflammatory Myofibroblastic Tumor Expressing a Novel Fusion, PPFIBP1–ALK: Reappraisal of Anti-ALK Immunohistochemistry as a Tool for Novel ALK Fusion Identification. Clinical Cancer Research. 17(10). 3341–3348. 77 indexed citations

6.

Takeuchi, Kengo, M Soda, Yosuke Togashi, et al.. (2010). Identification of a novel fusion, SQSTM1-ALK, in ALK-positive large B-cell lymphoma. Haematologica. 96(3). 464–467. 79 indexed citations

7.

Takeuchi, Kengo, Young Lim Choi, Yuki Togashi, et al.. (2009). KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer. Clinical Cancer Research. 15(9). 3143–3149. 557 indexed citations breakdown →

8.

Inamura, Kentaro, Kengo Takeuchi, Yuki Togashi, et al.. (2009). EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset. Modern Pathology. 22(4). 508–515. 360 indexed citations

9.

Choi, Young Lim, Kengo Takeuchi, Manabu Soda, et al.. (2008). Identification of Novel Isoforms of the EML4-ALK Transforming Gene in Non–Small Cell Lung Cancer. Cancer Research. 68(13). 4971–4976. 346 indexed citations

10.

Takeuchi, Kengo, Young Lim Choi, Manabu Soda, et al.. (2008). Multiplex Reverse Transcription-PCR Screening for EML4-ALK Fusion Transcripts. Clinical Cancer Research. 14(20). 6618–6624. 397 indexed citations

11.

Kondoh, Satoshi, et al.. (1999). Detection of K-ras and p53 Gene Mutations in Pancreatic Juice for the Diagnosis of Intraductal Papillary Mucinous Tumors. Pancreas. 18(3). 294–299. 32 indexed citations

12.

Kaino, Seiji, et al.. (1998). Two‐dimensional zymography for analysis of proteolytic enzymes in human pure pancreatic juice. Electrophoresis. 19(5). 782–787. 11 indexed citations

13.

Kondoh, Satoshi, et al.. (1996). p53 Mutations in Two Patients with Intraductal Papillary Adenoma of the Pancreas. Japanese Journal of Cancer Research. 87(12). 1195–1198. 12 indexed citations

14.

Minowa, Masumi, Satoko Hatano, Mai Ashizawa, et al.. (1991). A case-control study of lung cancer with special reference to asbestos exposure. Environmental Health Perspectives. 94. 39–42. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact